Tiankang Biology: Announcement of Resolutions of the 32nd (Provisional) Meeting of the Eighth Board of Directors

Tiankang Biotechnology

Securities code: 002100 Securities abbreviation: Tiankang Biology Announcement number: 2026-005

Tiankang Biological Co., Ltd.

Announcement of Resolutions of the 32nd (Extraordinary) Meeting of the Eighth Board of Directors

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.

The notice of the 32nd (temporary) meeting of the eighth session of the Board of Directors of Tiankang Biological Co., Ltd. (hereinafter referred to as the "Company") was issued by written personal delivery and email on January 28, 2026, and was held by communication voting at 11:00 am on February 2, 2026 (Thursday). There were 7 directors who should be present at the meeting, but 6 directors were actually present. Director Mr. Cheng Hui did not attend this meeting, nor did he entrust other directors to vote on his behalf. The company's senior managers attended the meeting. The meeting complied with the provisions of the Company Law and the Articles of Association, and was legal and valid. This meeting was chaired by Chairman Zhang Jie. After careful deliberation by the participants, the following resolutions were formed:

1. Proposal review status

(1) Review and approve the "Proposal on the General Election of Non-Independent Directors of the Ninth Board of Directors of the Company" item by item; (For details, please refer to the "Announcement of Tiankang Biological Co., Ltd. on the General Election of the Board of Directors" published on February 3, 2026 in the company's designated information disclosure newspaper "Securities Times" and the cninfo.com.cn website <Announcement Number: 2026-013>)

1.01 Mr. Zhang Jie was elected as the non-independent director of the company;

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

1.02 Mr. Xu Heng was elected as the company’s non-independent director;

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

1.03 Elected Ms. Dong Haiying as the company’s non-independent director;

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

1.04 Mr. Huang Haibin was elected as the company’s non-independent director;

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

This proposal has been reviewed and approved by the Nomination Committee of the Company’s Board of Directors.

This proposal must be submitted to the company's first extraordinary shareholders' meeting in 2026 for review.

Tiankang Biotechnology

(2) Review and adopt the "Proposal on the General Election of Independent Directors of the Ninth Board of Directors of the Company" item by item; (For details, please refer to the "Announcement of Tiankang Biological Co., Ltd. on the General Election of the Board of Directors" published on February 3, 2026 in the company's designated information disclosure newspaper "Securities Times" and the cninfo.com.cn website <Announcement No.: 2026-013>)

2.01 Mr. Li Gang was elected as the company’s independent director;

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

2.02 Mr. Chen Kefeng was elected as the company’s independent director;

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

2.03 Mr. Qu Yonggang was elected as the company’s independent director;

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

This proposal has been reviewed and approved by the Nomination Committee of the Company’s Board of Directors.

This proposal must be submitted to the company's first extraordinary shareholders' meeting in 2026 for review.

(3) Review and approve the company's "Proposal on Convening the First Extraordinary Shareholders' Meeting in 2026"; (For details, please refer to the "Notice of Tiankang Biological Co., Ltd. on Convening the First Extraordinary Shareholders' Meeting in 2026" published on February 3, 2026 in the company's designated information disclosure newspaper "Securities Times" and the cninfo.com.cn website (Announcement No.: 2026-006))

There were 6 votes in favor of the motion; 0 votes against; 0 abstentions;

2. Documents for reference

1. Resolution of the 32nd (extraordinary) meeting of the 8th Board of Directors;

2. Resolution of the first meeting of the Nomination Committee of the Eighth Board of Directors in 2026;

3. Other documents required by Shenzhen Stock Exchange.

Announcement is hereby made.

Board of Directors of Tiankang Biological Co., Ltd.

February 3, 2026 Tiankang Biology